Skip to main content

Table 2 Summary of systemic adjuvant treatment recommendations by modality and expertise

From: Computational prediction of multidisciplinary team decision-making for adjuvant breast cancer drug therapies: a machine learning approach

Adjuvant treatment Recommendation
Modality Expertise Recorded Recommended Not Recommended For discussion
   N (%) N (%) N (%) N (%)
Chemotherapy MDT 975 (92) 342 (35) 393 (40) 240 (25)
ESMO 1065 (100) 321 (30) 701 (66) 43 (4)
NCCN 1065 (100) 489 (46) 80 (8) 496 (47)
Endocrine therapy MDT 1002 (94) 794 (79) 86 (9) 122 (2)
ESMO 1065 (100) 927 (87) 138 (13) 0 (0)
NCCN 1065 (100) 874 (82) 143 (13) 48 (5)
Trastuzumab MDT 456 (43) 86 (19) 363 (80) 7 (2)
ESMO 1065 (100) 142 (13) 923 (87) 0 (0)
NCCN 1065 (100) 125 (12) 929 (87) 11 (1)
  1. MDT multidisciplinary conference, ESMO European society for medical oncology, NCCN national comprehensive cancer network